Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Testing effectiveness (Phase 2)Ended earlyNCT04030429What this trial is testingCrizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial CancerWho this might be right forEndometrial Cancer Recurrent National Cheng-Kung University Hospital 40
Early research (Phase 1)Study completedNCT00120939What this trial is testingStudy of Motexafin Gadolinium and Docetaxel for Advanced CancerWho this might be right forBreast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)Looking for participantsNCT06128551What this trial is testingStudy of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsWho this might be right forNon-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma Revolution Medicines, Inc. 534
Early research (Phase 1)Looking for participantsNCT05542407What this trial is testingONC201 and Atezolizumab in Obesity-Driven Endometrial CancerWho this might be right forEndometrial CancerMetastasisEndometrioid Endometrial Cancer+5 more UNC Lineberger Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT00003127What this trial is testingS9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial CancerWho this might be right forEndometrial Cancer SWOG Cancer Research Network 57
Early research (Phase 1)Study completedNCT00004082What this trial is testingCombination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial TumorsWho this might be right forEndometrial CancerFallopian Tube CancerOvarian Cancer+1 more Beth Israel Deaconess Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT05269381What this trial is testingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsWho this might be right forAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more Mayo Clinic 138
Testing effectiveness (Phase 2)Study completedNCT01935934What this trial is testingCabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial CancerWho this might be right forEndometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more National Cancer Institute (NCI) 102
Testing effectiveness (Phase 2)Temporarily pausedNCT04042116What this trial is testingEvaluate Lucitanib in Combination With Nivolumab in Patients With a Solid TumorWho this might be right forAdvanced Solid TumorGynecologic Cancer Clovis Oncology, Inc. 227
Early research (Phase 1)Ended earlyNCT03277482What this trial is testingDurvalumab, Tremelimumab + Radiotherapy in Gynecologic CancerWho this might be right forRecurrent Gynecological CancerMetastatic Cervical CancerMetastatic Ovarian Cancer+8 more Dana-Farber Cancer Institute 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT05538897What this trial is testingTesting the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial CancersWho this might be right forFIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaMetastatic Endometrial Endometrioid Adenocarcinoma+1 more National Cancer Institute (NCI)
Early research (Phase 1)Temporarily pausedNCT05958199What this trial is testingNPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7Who this might be right forMetastatic Malignant Neoplasm NextPoint Therapeutics, Inc. 131
Early research (Phase 1)Study completedNCT04293094What this trial is testingStudy of AMG 650 in Adult Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Volastra Therapeutics, Inc. 66
Very early researchLooking for participantsNCT06305962What this trial is testing177Lu-anti-PD-L1 sdAb in Metastatic Solid TumorsWho this might be right forPDL1 Gene MutationNon Small Cell Lung CancerSmall Cell Lung Cancer ( SCLC )+6 more Radiopharm Theranostics, Ltd 30
Early research (Phase 1)Looking for participantsNCT06270706What this trial is testingPLN-101095 in Adults With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumor Pliant Therapeutics, Inc. 124
Testing effectiveness (Phase 2)Looking for participantsNCT01174121What this trial is testingImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic CancerWho this might be right forMetastatic Colorectal CancerMetastatic Pancreatic CancerMetastatic Ovarian Cancer+2 more National Cancer Institute (NCI) 332
Testing effectiveness (Phase 2)Study completedNCT00095979What this trial is testingIxabepilone in Treating Patients With Recurrent or Persistent Endometrial CancerWho this might be right forEndometrial AdenocarcinomaRecurrent Endometrial CarcinomaStage IV Endometrial Carcinoma National Cancer Institute (NCI) 52
Early research (Phase 1)Study completedNCT02922764What this trial is testingRGX-104 in Patients With Advanced Lung & Endometrial CancerWho this might be right forEndometrial CancerEndometrial Cancer RecurrentLung Cancer Recurrent+3 more Inspirna, Inc. 146
Testing effectiveness (Phase 2)Looking for participantsNCT06532539What this trial is testingCadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial CarcinomaWho this might be right forEndometrial NeoplasmsNeoplasm Recurrence, LocalNeoplasm Metastasis Shandong Cancer Hospital and Institute 30